Amy Abernethy Announces She Is Leaving FDA

CBD regulation in the US  was dealt a setback Tuesday with the resignation of Dr. Amy Abernethy, who will leave the U.S. Food and Drug Administration in mid- to late April.

Abernethy’s resignation was announced in a memo from acting FDA Commissioner Janet Woodcock.

Abernethy has served as the FDA’s principal deputy commissioner and acting chief information officer since February 2019.

The Memo


Primary Sponsors

Get Connected

Karma Koala Podcast

Top Marijuana Blog